These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 16160736)

  • 1. Effect of testosterone replacement on trabecular architecture in hypogonadal men.
    Benito M; Vasilic B; Wehrli FW; Bunker B; Wald M; Gomberg B; Wright AC; Zemel B; Cucchiara A; Snyder PJ
    J Bone Miner Res; 2005 Oct; 20(10):1785-91. PubMed ID: 16160736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deterioration of trabecular architecture in hypogonadal men.
    Benito M; Gomberg B; Wehrli FW; Weening RH; Zemel B; Wright AC; Song HK; Cucchiara A; Snyder PJ
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1497-502. PubMed ID: 12679429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo microMRI-based finite element and morphological analyses of tibial trabecular bone in eugonadal and hypogonadal men before and after testosterone treatment.
    Zhang XH; Liu XS; Vasilic B; Wehrli FW; Benito M; Rajapakse CS; Snyder PJ; Guo XE
    J Bone Miner Res; 2008 Sep; 23(9):1426-34. PubMed ID: 18410234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of testosterone replacement in hypogonadal men.
    Snyder PJ; Peachey H; Berlin JA; Hannoush P; Haddad G; Dlewati A; Santanna J; Loh L; Lenrow DA; Holmes JH; Kapoor SC; Atkinson LE; Strom BL
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2670-7. PubMed ID: 10946864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone mineral density in hypogonadal men remains low after long-term testosterone replacement.
    Ishizaka K; Suzuki M; Kageyama Y; Kihara K; Yoshida K
    Asian J Androl; 2002 Jun; 4(2):117-21. PubMed ID: 12085102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effect of testosterone therapy on bone mineral density in hypogonadal men.
    Behre HM; Kliesch S; Leifke E; Link TM; Nieschlag E
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2386-90. PubMed ID: 9253305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of testosterone replacement therapy on cortical and trabecular bone mineral density, vertebral body area and paraspinal muscle area in hypogonadal men.
    Leifke E; Körner HC; Link TM; Behre HM; Peters PE; Nieschlag E
    Eur J Endocrinol; 1998 Jan; 138(1):51-8. PubMed ID: 9461316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism.
    Katznelson L; Finkelstein JS; Schoenfeld DA; Rosenthal DI; Anderson EJ; Klibanski A
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4358-65. PubMed ID: 8954042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo magnetic resonance detects rapid remodeling changes in the topology of the trabecular bone network after menopause and the protective effect of estradiol.
    Wehrli FW; Ladinsky GA; Jones C; Benito M; Magland J; Vasilic B; Popescu AM; Zemel B; Cucchiara AJ; Wright AC; Song HK; Saha PK; Peachey H; Snyder PJ
    J Bone Miner Res; 2008 May; 23(5):730-40. PubMed ID: 18251704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between simultaneous PSA and serum testosterone concentrations among eugonadal, untreated hypogonadal and hypogonadal men receiving testosterone replacement therapy.
    Grober ED; Lamb DJ; Khera M; Murthy L; Lipshultz LI
    Int J Impot Res; 2008; 20(6):561-5. PubMed ID: 18843272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effect of testosterone replacement therapy on bone in hypogonadal men with Klinefelter Syndrome.
    Tahani N; Nieddu L; Prossomariti G; Spaziani M; Granato S; Carlomagno F; Anzuini A; Lenzi A; Radicioni AF; Romagnoli E
    Endocrine; 2018 Aug; 61(2):327-335. PubMed ID: 29696556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone Therapy Effects on Bone Mass and Turnover in Hypogonadal Men with Type 2 Diabetes.
    Colleluori G; Aguirre L; Napoli N; Qualls C; Villareal DT; Armamento-Villareal R
    J Clin Endocrinol Metab; 2021 Jul; 106(8):e3058-e3068. PubMed ID: 33735389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of long-term testosterone substitutive therapy on bone mineral content in men with hypergonadotrophic hypogonadism.
    Medras M; Jankowska EA; Rogucka E
    Andrologia; 2001 Jan; 33(1):47-52. PubMed ID: 11167519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum adiponectin levels in hypogonadal males: influence of testosterone replacement therapy.
    Lanfranco F; Zitzmann M; Simoni M; Nieschlag E
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):500-7. PubMed ID: 15049966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in prostate specific antigen in hypogonadal men after 12 months of testosterone replacement therapy: support for the prostate saturation theory.
    Khera M; Bhattacharya RK; Blick G; Kushner H; Nguyen D; Miner MM
    J Urol; 2011 Sep; 186(3):1005-11. PubMed ID: 21788049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men--a clinical research center study.
    Wang C; Eyre DR; Clark R; Kleinberg D; Newman C; Iranmanesh A; Veldhuis J; Dudley RE; Berman N; Davidson T; Barstow TJ; Sinow R; Alexander G; Swerdloff RS
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3654-62. PubMed ID: 8855818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A biodegradable testosterone microcapsule formulation provides uniform eugonadal levels of testosterone for 10-11 weeks in hypogonadal men.
    Bhasin S; Swerdloff RS; Steiner B; Peterson MA; Meridores T; Galmirini M; Pandian MR; Goldberg R; Berman N
    J Clin Endocrinol Metab; 1992 Jan; 74(1):75-83. PubMed ID: 1727832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of hypogonadism and testosterone-enhancing therapy on alkaline phosphatase and bone mineral density.
    Dabaja AA; Bryson CF; Schlegel PN; Paduch DA
    BJU Int; 2015 Mar; 115(3):480-5. PubMed ID: 25046796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of testosterone and venesection on spinal and peripheral bone mineral in six hypogonadal men with hemochromatosis.
    Diamond T; Stiel D; Posen S
    J Bone Miner Res; 1991 Jan; 6(1):39-43. PubMed ID: 2048430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trabecular structure quantified with the MRI-based virtual bone biopsy in postmenopausal women contributes to vertebral deformity burden independent of areal vertebral BMD.
    Ladinsky GA; Vasilic B; Popescu AM; Wald M; Zemel BS; Snyder PJ; Loh L; Song HK; Saha PK; Wright AC; Wehrli FW
    J Bone Miner Res; 2008 Jan; 23(1):64-74. PubMed ID: 17784842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.